$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Earnings Estimates Moving Higher for Haemonetics (HAE): Time to Buy?
01:24pm, Friday, 02'nd Jun 2023
Haemonetics (HAE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Haemonetics (HAE) Hospital Arm Grows, Plasma Volume Improves
12:36pm, Thursday, 01'st Jun 2023
Within Haemonetics (HAE) Vascular Closure, growth is led by the opening of new accounts and increasing penetration to gain share in the top U.S. EP hospitals.
Here's Why You Should Invest in Haemonetics (HAE) Right Now
01:16pm, Wednesday, 31'st May 2023
Investors are optimistic about Haemonetics (HAE), led by the impressive performance of Plasma and Hospital businesses.
How Much Upside is Left in Haemonetics (HAE)? Wall Street Analysts Think 27.09%
11:05am, Friday, 26'th May 2023
The mean of analysts' price targets for Haemonetics (HAE) points to a 27.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy
New Strong Buy Stocks for May 26th
10:20am, Friday, 26'th May 2023
HDELY, WIRE, HAE, GWW and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on May 26, 2023.
HAE or PODD: Which Is the Better Value Stock Right Now?
12:50pm, Monday, 22'nd May 2023
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Insulet (PODD). But which of these two stocks presents investors with the better value opport
Haemonetics Corporation: Premium Blood Play
01:20pm, Thursday, 18'th May 2023
Haemonetics Corporation is showing signs of operational momentum again post-pandemic. After a painful 2021, amidst fears of customer losses, Haemonetics Corporation shares and the company have shown a
Haemonetics: Attracting Investment Through Capital Recycling Initiatives
05:43am, Tuesday, 16'th May 2023
Investors continue to reward Haemonetics with higher market valuations in 2023. Driving these trends are the firm's attractive underlying economic characteristics.
Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
09:56am, Friday, 12'th May 2023
Amid a challenging economic environment, Haemonetics (HAE) delivers impressive fiscal fourth-quarter organic revenues, led by the stellar performance across the Plasma and Hospital business.
Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
09:10am, Thursday, 11'th May 2023
Haemonetics (HAE) came out with quarterly earnings of $0.77 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.65 per share a year ago.
VREX or HAE: Which Is the Better Value Stock Right Now?
01:41pm, Thursday, 04'th May 2023
Investors looking for stocks in the Medical - Products sector might want to consider either VAREX IMAGING (VREX) or Haemonetics (HAE). But which of these two companies is the best option for those loo
HAE vs. SYK: Which Stock Is the Better Value Option?
12:55pm, Friday, 14'th Apr 2023
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their b
Here's Why You Should Invest in Haemonetics (HAE) Right Now
01:42pm, Tuesday, 04'th Apr 2023
Investors are upbeat about Haemonetics (HAE) owing to impressive Plasma and Hospital business performance, with continued strength in the Hemostasis Management product line.
4 Low-Beta Stocks to Buy to Endure Market Volatility
08:24am, Tuesday, 04'th Apr 2023
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Haemonetics (HAE), The Kroger Co. (KR), JOYY (YY) and Novo Nordisk (NVO) are poised to gain.
HAE vs. SYK: Which Stock Should Value Investors Buy Now?
12:59pm, Friday, 24'th Mar 2023
HAE vs. SYK: Which Stock Is the Better Value Option?
Sign In
Buy HAE